Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration

Clinical trial NCT07040137 · RECRUITING

Trial details

NCT number: NCT07040137
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Spinocerebellar Degeneration

Start date: 2025-07-01
Primary completion: 2027-03-31
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.